The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Deuterated Drugs-Global Market Insights and Sales Trends 2025
Synopsis
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
The global Deuterated Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Deuterated Drugs in various end use industries. The expanding demands from the Huntington'S Disease (HD), Tardive Dyskinesia (TD), Cancer and Others, are propelling Deuterated Drugs market. Austedo, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Zepsun segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Deuterated Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Deuterated Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Deuterated Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Deuterated Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Deuterated Drugs covered in this report include Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir) and Poxel SA (DeuteRx), etc.
The global Deuterated Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
Global Deuterated Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Deuterated Drugs market, Segment by Type:
Austedo
Zepsun
Others
Global Deuterated Drugs market, by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A deuterated drug is a small molecule medicinal product in which one or more of the hydrogen atoms contained in the drug molecule have been replaced by its heavier stable isotope deuterium. Because of the kinetic isotope effect, deuterium-containing drugs may have significantly lower rates of metabolism, and hence a longer half-life.
The global Deuterated Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Deuterated Drugs in various end use industries. The expanding demands from the Huntington'S Disease (HD), Tardive Dyskinesia (TD), Cancer and Others, are propelling Deuterated Drugs market. Austedo, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Zepsun segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Deuterated Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Deuterated Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Deuterated Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Deuterated Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Deuterated Drugs covered in this report include Teva, Suzhou Zelgen Biopharmaceuticals, Concert Pharmaceuticals, Vertex Pharmaceuticals, Hinova Pharma, Otsuka Pharmaceutical (Avanir) and Poxel SA (DeuteRx), etc.
The global Deuterated Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Suzhou Zelgen Biopharmaceuticals
Concert Pharmaceuticals
Vertex Pharmaceuticals
Hinova Pharma
Otsuka Pharmaceutical (Avanir)
Poxel SA (DeuteRx)
Global Deuterated Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Deuterated Drugs market, Segment by Type:
Austedo
Zepsun
Others
Global Deuterated Drugs market, by Application
Huntington'S Disease (HD)
Tardive Dyskinesia (TD)
Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Deuterated Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Deuterated Drugs
1.1 Deuterated Drugs Market Overview
1.1.1 Deuterated Drugs Product Scope
1.1.2 Deuterated Drugs Market Status and Outlook
1.2 Global Deuterated Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Deuterated Drugs Market Size by Region (2018-2029)
1.4 Global Deuterated Drugs Historic Market Size by Region (2018-2023)
1.5 Global Deuterated Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Deuterated Drugs Market Size (2018-2029)
1.6.1 North America Deuterated Drugs Market Size (2018-2029)
1.6.2 Europe Deuterated Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Deuterated Drugs Market Size (2018-2029)
1.6.4 Latin America Deuterated Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Deuterated Drugs Market Size (2018-2029)
2 Deuterated Drugs Market by Type
2.1 Introduction
2.1.1 Austedo
2.1.2 Zepsun
2.1.3 Others
2.2 Global Deuterated Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Deuterated Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Deuterated Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Deuterated Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Deuterated Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Deuterated Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Deuterated Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Deuterated Drugs Revenue Breakdown by Type (2018-2029)
3 Deuterated Drugs Market Overview by Application
3.1 Introduction
3.1.1 Huntington'S Disease (HD)
3.1.2 Tardive Dyskinesia (TD)
3.1.3 Cancer
3.1.4 Others
3.2 Global Deuterated Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Deuterated Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Deuterated Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Deuterated Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Deuterated Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Deuterated Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Deuterated Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Deuterated Drugs Revenue Breakdown by Application (2018-2029)
4 Deuterated Drugs Competition Analysis by Players
4.1 Global Deuterated Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Deuterated Drugs as of 2022)
4.3 Date of Key Players Enter into Deuterated Drugs Market
4.4 Global Top Players Deuterated Drugs Headquarters and Area Served
4.5 Key Players Deuterated Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Deuterated Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva
5.1.1 Teva Profile
5.1.2 Teva Main Business
5.1.3 Teva Deuterated Drugs Products, Services and Solutions
5.1.4 Teva Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Recent Developments
5.2 Suzhou Zelgen Biopharmaceuticals
5.2.1 Suzhou Zelgen Biopharmaceuticals Profile
5.2.2 Suzhou Zelgen Biopharmaceuticals Main Business
5.2.3 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Products, Services and Solutions
5.2.4 Suzhou Zelgen Biopharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
5.3 Concert Pharmaceuticals
5.3.1 Concert Pharmaceuticals Profile
5.3.2 Concert Pharmaceuticals Main Business
5.3.3 Concert Pharmaceuticals Deuterated Drugs Products, Services and Solutions
5.3.4 Concert Pharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Vertex Pharmaceuticals Recent Developments
5.4 Vertex Pharmaceuticals
5.4.1 Vertex Pharmaceuticals Profile
5.4.2 Vertex Pharmaceuticals Main Business
5.4.3 Vertex Pharmaceuticals Deuterated Drugs Products, Services and Solutions
5.4.4 Vertex Pharmaceuticals Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Vertex Pharmaceuticals Recent Developments
5.5 Hinova Pharma
5.5.1 Hinova Pharma Profile
5.5.2 Hinova Pharma Main Business
5.5.3 Hinova Pharma Deuterated Drugs Products, Services and Solutions
5.5.4 Hinova Pharma Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Hinova Pharma Recent Developments
5.6 Otsuka Pharmaceutical (Avanir)
5.6.1 Otsuka Pharmaceutical (Avanir) Profile
5.6.2 Otsuka Pharmaceutical (Avanir) Main Business
5.6.3 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Products, Services and Solutions
5.6.4 Otsuka Pharmaceutical (Avanir) Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Otsuka Pharmaceutical (Avanir) Recent Developments
5.7 Poxel SA (DeuteRx)
5.7.1 Poxel SA (DeuteRx) Profile
5.7.2 Poxel SA (DeuteRx) Main Business
5.7.3 Poxel SA (DeuteRx) Deuterated Drugs Products, Services and Solutions
5.7.4 Poxel SA (DeuteRx) Deuterated Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Poxel SA (DeuteRx) Recent Developments
6 North America
6.1 North America Deuterated Drugs Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Deuterated Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Deuterated Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Deuterated Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Deuterated Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Deuterated Drugs Market Dynamics
11.1 Deuterated Drugs Industry Trends
11.2 Deuterated Drugs Market Drivers
11.3 Deuterated Drugs Market Challenges
11.4 Deuterated Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
